XML 101 R27.htm IDEA: XBRL DOCUMENT
v3.26.1

Loss Per Share (Tables) | 3 Months Ended
--- | ---
Mar. 31, 2026
Earnings Per Share [Abstract] |
Schedule of antidilutive securities excluded from computation of earnings per share | The following outstanding potentially dilutive common stock equivalents were excluded from the computation of diluted net loss per share for the periods presented because including them would have been antidilutive (in thousands):
| March 31,
| 2026 |  | 2025
K2 Common Stock Warrants | 170 |  |  | 170 |
Restricted Stock Units | — |  |  | 54 |
Stock options issued and outstanding | 7,078 |  |  | 5,651 |
Total | 7,248 |  |  | 5,875 |

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 + Details
Name: | us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration